共 39 条
- [31] Recommendations in the American College of Rheumatology guideline for the treatment of rheumatoid arthritis related to the use of biologic agents in patients with a history of cancer need reconsideration: comment on the article by Singh et al Reply ARTHRITIS & RHEUMATOLOGY, 2016, 68 (05) : 1316 - 1318
- [32] Recommendations in the American College of Rheumatology guideline for the treatment of rheumatoid arthritis related to the use of biologic agents in patients with a history of cancer need reconsideration: comment on the article by Singh et al Reply ARTHRITIS CARE & RESEARCH, 2016, 68 (05) : 725 - 726
- [34] Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab ARTHRITIS CARE & RESEARCH, 2017, 69 (05) : 609 - 615
- [35] Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Against Rheumatism: Patient Reported Outcomes Analyzed From 3 Phase III Golimumab Trials. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S35 - S36
- [36] VALIDATION OF REMISSION OF RHEUMATOID ARTHRITIS BY TRADITIONAL DISEASE ACTIVITY SCORE AND PROVISIONAL CRITERIA BY AMERICAN COLLEGE OF RHEUMATOLOGY AND EUROPEAN LEAGUE AGAISNT RHEUMATISM: ANALYSIS BASED ON PATIENT REPORTED OUTCOMES FROM 3 PHASE III CLINICAL TRIALS OF GOLIMUMAB VALUE IN HEALTH, 2012, 15 (04) : A43 - A43
- [37] Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Against Rheumatism: Analysis Based on Patient Reported Outcomes Analyzed from 3 Phase III Golimumab Clinical Trials of Golimumab JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 968 - 969
- [38] VALIDATION OF REMISSION OF RHEUMATOID ARTHRITIS BY TRADITIONAL DISEASE ACTIVITY SCORE AND PROVISIONAL CRITERIA BY AMERICAN COLLEGE OF RHEUMATOLOGY AND EUROPEAN LEAGUE AGAINST RHEUMATISM: ANALYSIS BASED ON PATIENT-REPORTED OUTCOMES ANALYSED FROM THREE PHASE III GOLIMUMAB CLINICAL TRIALS RHEUMATOLOGY, 2013, 52 : 83 - 83
- [39] An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the disease activity score (DAS) in a rheumatoid arthritis clinical trial ARTHRITIS AND RHEUMATISM, 2003, 48 (03): : 625 - 630